Customizable virus-like particles deliver CRISPR–Cas9 ribonucleoprotein for effective ocular neovascular and Huntington’s disease gene therapy
Sikai Ling(Shanghai Jiao Tong University), Yujia Cai(Shanghai Jiao Tong University)
Cited by 63
Related Papers
Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
|Nature Biotechnology|2021|178
A single dose SARS-CoV-2 simulating particle vaccine induces potent neutralizing activities
|bioRxiv (Cold Spring Harbor Laboratory)|2020|10
Immunostimulatory guide RNAs mediate potent antiviral response
|bioRxiv (Cold Spring Harbor Laboratory)|2018|2
Intracorneal delivery of HSV-targeting CRISPR/Cas9 mRNA prevents herpetic stromal keratitis
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0